{
    "root": "357e3e68-dd25-abee-e063-6394a90afda5",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Amoxicillin",
    "value": "20250509",
    "ingredients": [
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "CROSPOVIDONE (120 .MU.M)",
            "code": "68401960MK"
        },
        {
            "name": "D&C RED NO. 30",
            "code": "2S42T2808B"
        },
        {
            "name": "HYPROMELLOSE 2910 (6 MPA.S)",
            "code": "0WZ8WG20P6"
        },
        {
            "name": "HYPROMELLOSE 2910 (15 MPA.S)",
            "code": "36SFW2JZ0W"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "POLYETHYLENE GLYCOL 3350",
            "code": "G2M7P15E5P"
        },
        {
            "name": "POLYETHYLENE GLYCOL 8000",
            "code": "Q662QK8M3B"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "AMOXICILLIN",
            "code": "804826J2HU"
        }
    ],
    "indications": "Adults and Pediatric Patients\n                  \n                  \n                     \n                        Upper Respiratory Tract Infections of the Ear, Nose, and Throat:Amoxicillin tablets are indicated in the treatment of infections due to susceptible (ONLY β-lactamase-negative) isolates of\n  \n   Streptococcusspecies. (α- and β-hemolytic isolates only),\n  \n   Streptococcus pneumoniae,\n  \n   Staphylococcusspp., or\n  \n   Haemophilus influenzae.\n \n  \n                  \n                  \n                  \n                     \n                        Infections of the Genitourinary Tract:Amoxicillin tablets are indicated in the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of\n  \n   Escherichia coli, Proteus mirabilis, or\n  \n   Enterococcus faecalis. \n \n  \n                  \n                  \n                  \n                     \n                        Infections of the Skin and Skin Structure:Amoxicillin tablets are indicated in the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of\n  \n   Streptococcusspp. (α- and β-hemolytic isolates only),\n  \n   Staphylococcusspp., or\n  \n   E. coli.\n \n  \n                  \n                  \n                  \n                     \n                        Infections of the Lower Respiratory Tract:Amoxicillin tablets are indicated in the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of\n  \n   Streptococcusspp. (α- and β-hemolytic isolates only),\n  \n   S. pneumoniae, Staphylococcusspp., or\n  \n   H. influenzae. \n \n  \n                  \n                  \n                  \n                     Adult Patients only\n                  \n                  \n                     \n                        \n                           Helicobacter pylori\n                        \n                        Infection and Duodenal Ulcer Disease:\n                     \n                  \n                  \n                     Triple therapy for\n  \n   Helicobacter pylori (H. pylori)with clarithromycin and lansoprazole:\n \n  \n                       \n   \n                     Amoxicillin tablets, in combination with clarithromycin plus lansoprazole as triple therapy, are indicated for the treatment of patients with\n \n  H. pyloriinfection and duodenal ulcer disease (active or 1-year history of a duodenal ulcer) to eradicate\n \n  H. pylori. Eradication of\n \n  H. pylorihas been shown to reduce the risk of duodenal ulcer recurrence.\n\n \n                  \n                  \n                     Dual therapy for\n  \n   H. pyloriwith lansoprazole\n \n  \n                     :  Amoxicillin tablets, in combination with lansoprazole delayed-release capsules as dual therapy, are indicated for the treatment of patients with\n \n  H. pyloriinfection and duodenal ulcer disease (active or 1-year history of a duodenal ulcer)\n \n  who are either allergic or intolerant to clarithromycin or in whom resistance to clarithromycin is known or suspected. (See the clarithromycin package insert, MICROBIOLOGY.) Eradication of\n \n  H. pylorihas been shown to reduce the risk of duodenal ulcer recurrence.\n\n \n                  \n                  \n                     Usage\n                  \n                  \n                  To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin tablets and other antibacterial drugs, amoxicillin tablets should be used only to treat infections that are proven or strongly suspected to be caused by bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.",
    "contraindications": "In Adults, 750 to 1750 mg/day in divided doses every 8 to 12 hours. In Pediatric Patients over 3 Months of Age, 20 to 45 mg/kg/day in divided doses every 8 to 12 hours. Refer to full prescribing information for specific dosing regimens. ( 2.2 , 2.3 ) The upper dose for neonates and infants aged 3 months or younger is 30 mg/kg/day divided every 12 hours. ( 2.3 ) Dosing for H. pylori Infection (in Adults): Triple therapy: 1 gram amoxicillin, 500 mg clarithromycin, and 30 mg lansoprazole, all given twice daily (every 12 hours) for 14 days. Dual therapy: 1 gram amoxicillin and 30 mg lansoprazole, each given three times daily (every 8 hours) for 14 days. ( 2.4 ) Reduce the dose in patients with severe renal impairment (GFR greater than 30 mL/min). ( 2.5 )",
    "warningsAndPrecautions": "Amoxicillin Tablets, USPcontains 875 mg amoxicillin as the trihydrate.\n  \n                     \n                     875 mg Tablet\n                     \n                     \nPink colored, capsule shaped, film coated tablets debossed with “A” on one side and with a score line in between “6” and “7” on the other side.\n  \n                     \n      Bottles of 20 NDC 42708-078-20\n  \n                     \n                     Store at20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Dispense in a tight container.",
    "adverseReactions": "Amoxicillin tablets are contraindicated in patients who have experienced a serious hypersensitivity reaction (e.g., anaphylaxis or Stevens-Johnson syndrome) to amoxicillin tablets or to other β-lactam antibacterial drugs (e.g., penicillins and cephalosporins)."
}